Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2002

01-05-2002

Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative Evaluation

Authors: Anton Haid, Roswitha Köberle-Wührer, Michael Knauer, Judit Burtscher, Heinz Fritzsche, William Peschina, Zerina Jasarevic, Maria Ammann, Klaus Hergan, Heinz Sturn, Gerhard Zimmermann

Published in: Breast Cancer Research and Treatment | Issue 1/2002

Login to get access
Metadata
Title
Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative Evaluation
Authors
Anton Haid
Roswitha Köberle-Wührer
Michael Knauer
Judit Burtscher
Heinz Fritzsche
William Peschina
Zerina Jasarevic
Maria Ammann
Klaus Hergan
Heinz Sturn
Gerhard Zimmermann
Publication date
01-05-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1015234318582

Other articles of this Issue 1/2002

Breast Cancer Research and Treatment 1/2002 Go to the issue

OriginalPaper

The Influence of the Route of Administration of 17β-estradiol, Intravenous (Pulsed) Versus Oral, Upon DMBA-Induced Mammary Tumour Development in Ovariectomised Rats

OriginalPaper

Blood Vessel Invasion as a Predictor of Long-Term Survival for Japanese Patients with Breast Cancer

OriginalPaper

Impact of Videotaped Information on Frequency and Confidence of Breast Self-Examination

OriginalPaper

Weekly Paclitaxel in Women Age 65 and Above with Metastatic Breast Cancer*

OriginalPaper

Effect of Selective Ablation of Proliferating Mammary Epithelial Cells on MNU Induced Rat Mammary Tumorigenesis

OriginalPaper

Letter to the Editor
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits